A step towards understanding early interventions for Huntington’s Disease
Huntington’s Disease is the most common neurodegenerative disorder controlled by a single gene and is characterized by motor and cognitive deficits and psychiatric symptoms. Currently, no treatments can stop or reverse the disease, but new research from Boston Children’s Hospital suggests that there might be a way to protect the brain and prevent or slow cognitive decline.
Research from the lab of Beth Stevens, PhD suggests that parts of the immune system – complement proteins and microglia – mediate the loss of specific synapses connecting the brain’s cortex and striatum. The findings, recently published in Nature Medicine, could ...










